Global 3rd Generation EGFR Market Growth 2023-2029

February 2023 | 72 pages | ID: G1D184162FD5EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “3rd Generation EGFR Industry Forecast” looks at past sales and reviews total world 3rd Generation EGFR sales in 2022, providing a comprehensive analysis by region and market sector of projected 3rd Generation EGFR sales for 2023 through 2029. With 3rd Generation EGFR sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 3rd Generation EGFR industry.

This Insight Report provides a comprehensive analysis of the global 3rd Generation EGFR landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 3rd Generation EGFR portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global 3rd Generation EGFR market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 3rd Generation EGFR and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 3rd Generation EGFR.

The global 3rd Generation EGFR market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for 3rd Generation EGFR is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for 3rd Generation EGFR is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for 3rd Generation EGFR is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key 3rd Generation EGFR players cover Shanghai Allist Pharmaceuticals, Betta Pharmaceuticals and Nanjing Sanhome Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of 3rd Generation EGFR market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Monoclonal Antibody Class
• Small Molecule Tyrosine Kinase Inhibitors (TKIs)

Segmentation by application

• Lung Cancer
• Liver Cancer
• Stomach Cancer
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Shanghai Allist Pharmaceuticals
• Betta Pharmaceuticals
• Nanjing Sanhome Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global 3rd Generation EGFR market?

What factors are driving 3rd Generation EGFR market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do 3rd Generation EGFR market opportunities vary by end market size?

How does 3rd Generation EGFR break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global 3rd Generation EGFR Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for 3rd Generation EGFR by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for 3rd Generation EGFR by Country/Region, 2018, 2022 & 2029
2.2 3rd Generation EGFR Segment by Type
  2.2.1 Monoclonal Antibody Class
  2.2.2 Small Molecule Tyrosine Kinase Inhibitors (TKIs)
2.3 3rd Generation EGFR Sales by Type
  2.3.1 Global 3rd Generation EGFR Sales Market Share by Type (2018-2023)
  2.3.2 Global 3rd Generation EGFR Revenue and Market Share by Type (2018-2023)
  2.3.3 Global 3rd Generation EGFR Sale Price by Type (2018-2023)
2.4 3rd Generation EGFR Segment by Application
  2.4.1 Lung Cancer
  2.4.2 Liver Cancer
  2.4.3 Stomach Cancer
  2.4.4 Other
2.5 3rd Generation EGFR Sales by Application
  2.5.1 Global 3rd Generation EGFR Sale Market Share by Application (2018-2023)
  2.5.2 Global 3rd Generation EGFR Revenue and Market Share by Application (2018-2023)
  2.5.3 Global 3rd Generation EGFR Sale Price by Application (2018-2023)

3 GLOBAL 3RD GENERATION EGFR BY COMPANY

3.1 Global 3rd Generation EGFR Breakdown Data by Company
  3.1.1 Global 3rd Generation EGFR Annual Sales by Company (2018-2023)
  3.1.2 Global 3rd Generation EGFR Sales Market Share by Company (2018-2023)
3.2 Global 3rd Generation EGFR Annual Revenue by Company (2018-2023)
  3.2.1 Global 3rd Generation EGFR Revenue by Company (2018-2023)
  3.2.2 Global 3rd Generation EGFR Revenue Market Share by Company (2018-2023)
3.3 Global 3rd Generation EGFR Sale Price by Company
3.4 Key Manufacturers 3rd Generation EGFR Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers 3rd Generation EGFR Product Location Distribution
  3.4.2 Players 3rd Generation EGFR Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR 3RD GENERATION EGFR BY GEOGRAPHIC REGION

4.1 World Historic 3rd Generation EGFR Market Size by Geographic Region (2018-2023)
  4.1.1 Global 3rd Generation EGFR Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global 3rd Generation EGFR Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic 3rd Generation EGFR Market Size by Country/Region (2018-2023)
  4.2.1 Global 3rd Generation EGFR Annual Sales by Country/Region (2018-2023)
  4.2.2 Global 3rd Generation EGFR Annual Revenue by Country/Region (2018-2023)
4.3 Americas 3rd Generation EGFR Sales Growth
4.4 APAC 3rd Generation EGFR Sales Growth
4.5 Europe 3rd Generation EGFR Sales Growth
4.6 Middle East & Africa 3rd Generation EGFR Sales Growth

5 AMERICAS

5.1 Americas 3rd Generation EGFR Sales by Country
  5.1.1 Americas 3rd Generation EGFR Sales by Country (2018-2023)
  5.1.2 Americas 3rd Generation EGFR Revenue by Country (2018-2023)
5.2 Americas 3rd Generation EGFR Sales by Type
5.3 Americas 3rd Generation EGFR Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC 3rd Generation EGFR Sales by Region
  6.1.1 APAC 3rd Generation EGFR Sales by Region (2018-2023)
  6.1.2 APAC 3rd Generation EGFR Revenue by Region (2018-2023)
6.2 APAC 3rd Generation EGFR Sales by Type
6.3 APAC 3rd Generation EGFR Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe 3rd Generation EGFR by Country
  7.1.1 Europe 3rd Generation EGFR Sales by Country (2018-2023)
  7.1.2 Europe 3rd Generation EGFR Revenue by Country (2018-2023)
7.2 Europe 3rd Generation EGFR Sales by Type
7.3 Europe 3rd Generation EGFR Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa 3rd Generation EGFR by Country
  8.1.1 Middle East & Africa 3rd Generation EGFR Sales by Country (2018-2023)
  8.1.2 Middle East & Africa 3rd Generation EGFR Revenue by Country (2018-2023)
8.2 Middle East & Africa 3rd Generation EGFR Sales by Type
8.3 Middle East & Africa 3rd Generation EGFR Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 3rd Generation EGFR
10.3 Manufacturing Process Analysis of 3rd Generation EGFR
10.4 Industry Chain Structure of 3rd Generation EGFR

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 3rd Generation EGFR Distributors
11.3 3rd Generation EGFR Customer

12 WORLD FORECAST REVIEW FOR 3RD GENERATION EGFR BY GEOGRAPHIC REGION

12.1 Global 3rd Generation EGFR Market Size Forecast by Region
  12.1.1 Global 3rd Generation EGFR Forecast by Region (2024-2029)
  12.1.2 Global 3rd Generation EGFR Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global 3rd Generation EGFR Forecast by Type
12.7 Global 3rd Generation EGFR Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Shanghai Allist Pharmaceuticals
  13.1.1 Shanghai Allist Pharmaceuticals Company Information
  13.1.2 Shanghai Allist Pharmaceuticals 3rd Generation EGFR Product Portfolios and Specifications
  13.1.3 Shanghai Allist Pharmaceuticals 3rd Generation EGFR Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Shanghai Allist Pharmaceuticals Main Business Overview
  13.1.5 Shanghai Allist Pharmaceuticals Latest Developments
13.2 Betta Pharmaceuticals
  13.2.1 Betta Pharmaceuticals Company Information
  13.2.2 Betta Pharmaceuticals 3rd Generation EGFR Product Portfolios and Specifications
  13.2.3 Betta Pharmaceuticals 3rd Generation EGFR Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Betta Pharmaceuticals Main Business Overview
  13.2.5 Betta Pharmaceuticals Latest Developments
13.3 Nanjing Sanhome Pharmaceutical
  13.3.1 Nanjing Sanhome Pharmaceutical Company Information
  13.3.2 Nanjing Sanhome Pharmaceutical 3rd Generation EGFR Product Portfolios and Specifications
  13.3.3 Nanjing Sanhome Pharmaceutical 3rd Generation EGFR Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Nanjing Sanhome Pharmaceutical Main Business Overview
  13.3.5 Nanjing Sanhome Pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. 3rd Generation EGFR Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. 3rd Generation EGFR Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Monoclonal Antibody Class
Table 4. Major Players of Small Molecule Tyrosine Kinase Inhibitors (TKIs)
Table 5. Global 3rd Generation EGFR Sales by Type (2018-2023) & (K Pcs)
Table 6. Global 3rd Generation EGFR Sales Market Share by Type (2018-2023)
Table 7. Global 3rd Generation EGFR Revenue by Type (2018-2023) & ($ million)
Table 8. Global 3rd Generation EGFR Revenue Market Share by Type (2018-2023)
Table 9. Global 3rd Generation EGFR Sale Price by Type (2018-2023) & (US$/Pcs)
Table 10. Global 3rd Generation EGFR Sales by Application (2018-2023) & (K Pcs)
Table 11. Global 3rd Generation EGFR Sales Market Share by Application (2018-2023)
Table 12. Global 3rd Generation EGFR Revenue by Application (2018-2023)
Table 13. Global 3rd Generation EGFR Revenue Market Share by Application (2018-2023)
Table 14. Global 3rd Generation EGFR Sale Price by Application (2018-2023) & (US$/Pcs)
Table 15. Global 3rd Generation EGFR Sales by Company (2018-2023) & (K Pcs)
Table 16. Global 3rd Generation EGFR Sales Market Share by Company (2018-2023)
Table 17. Global 3rd Generation EGFR Revenue by Company (2018-2023) ($ Millions)
Table 18. Global 3rd Generation EGFR Revenue Market Share by Company (2018-2023)
Table 19. Global 3rd Generation EGFR Sale Price by Company (2018-2023) & (US$/Pcs)
Table 20. Key Manufacturers 3rd Generation EGFR Producing Area Distribution and Sales Area
Table 21. Players 3rd Generation EGFR Products Offered
Table 22. 3rd Generation EGFR Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global 3rd Generation EGFR Sales by Geographic Region (2018-2023) & (K Pcs)
Table 26. Global 3rd Generation EGFR Sales Market Share Geographic Region (2018-2023)
Table 27. Global 3rd Generation EGFR Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global 3rd Generation EGFR Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global 3rd Generation EGFR Sales by Country/Region (2018-2023) & (K Pcs)
Table 30. Global 3rd Generation EGFR Sales Market Share by Country/Region (2018-2023)
Table 31. Global 3rd Generation EGFR Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global 3rd Generation EGFR Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas 3rd Generation EGFR Sales by Country (2018-2023) & (K Pcs)
Table 34. Americas 3rd Generation EGFR Sales Market Share by Country (2018-2023)
Table 35. Americas 3rd Generation EGFR Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas 3rd Generation EGFR Revenue Market Share by Country (2018-2023)
Table 37. Americas 3rd Generation EGFR Sales by Type (2018-2023) & (K Pcs)
Table 38. Americas 3rd Generation EGFR Sales by Application (2018-2023) & (K Pcs)
Table 39. APAC 3rd Generation EGFR Sales by Region (2018-2023) & (K Pcs)
Table 40. APAC 3rd Generation EGFR Sales Market Share by Region (2018-2023)
Table 41. APAC 3rd Generation EGFR Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC 3rd Generation EGFR Revenue Market Share by Region (2018-2023)
Table 43. APAC 3rd Generation EGFR Sales by Type (2018-2023) & (K Pcs)
Table 44. APAC 3rd Generation EGFR Sales by Application (2018-2023) & (K Pcs)
Table 45. Europe 3rd Generation EGFR Sales by Country (2018-2023) & (K Pcs)
Table 46. Europe 3rd Generation EGFR Sales Market Share by Country (2018-2023)
Table 47. Europe 3rd Generation EGFR Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe 3rd Generation EGFR Revenue Market Share by Country (2018-2023)
Table 49. Europe 3rd Generation EGFR Sales by Type (2018-2023) & (K Pcs)
Table 50. Europe 3rd Generation EGFR Sales by Application (2018-2023) & (K Pcs)
Table 51. Middle East & Africa 3rd Generation EGFR Sales by Country (2018-2023) & (K Pcs)
Table 52. Middle East & Africa 3rd Generation EGFR Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa 3rd Generation EGFR Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa 3rd Generation EGFR Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa 3rd Generation EGFR Sales by Type (2018-2023) & (K Pcs)
Table 56. Middle East & Africa 3rd Generation EGFR Sales by Application (2018-2023) & (K Pcs)
Table 57. Key Market Drivers & Growth Opportunities of 3rd Generation EGFR
Table 58. Key Market Challenges & Risks of 3rd Generation EGFR
Table 59. Key Industry Trends of 3rd Generation EGFR
Table 60. 3rd Generation EGFR Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. 3rd Generation EGFR Distributors List
Table 63. 3rd Generation EGFR Customer List
Table 64. Global 3rd Generation EGFR Sales Forecast by Region (2024-2029) & (K Pcs)
Table 65. Global 3rd Generation EGFR Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas 3rd Generation EGFR Sales Forecast by Country (2024-2029) & (K Pcs)
Table 67. Americas 3rd Generation EGFR Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC 3rd Generation EGFR Sales Forecast by Region (2024-2029) & (K Pcs)
Table 69. APAC 3rd Generation EGFR Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe 3rd Generation EGFR Sales Forecast by Country (2024-2029) & (K Pcs)
Table 71. Europe 3rd Generation EGFR Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa 3rd Generation EGFR Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Middle East & Africa 3rd Generation EGFR Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global 3rd Generation EGFR Sales Forecast by Type (2024-2029) & (K Pcs)
Table 75. Global 3rd Generation EGFR Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global 3rd Generation EGFR Sales Forecast by Application (2024-2029) & (K Pcs)
Table 77. Global 3rd Generation EGFR Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Shanghai Allist Pharmaceuticals Basic Information, 3rd Generation EGFR Manufacturing Base, Sales Area and Its Competitors
Table 79. Shanghai Allist Pharmaceuticals 3rd Generation EGFR Product Portfolios and Specifications
Table 80. Shanghai Allist Pharmaceuticals 3rd Generation EGFR Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 81. Shanghai Allist Pharmaceuticals Main Business
Table 82. Shanghai Allist Pharmaceuticals Latest Developments
Table 83. Betta Pharmaceuticals Basic Information, 3rd Generation EGFR Manufacturing Base, Sales Area and Its Competitors
Table 84. Betta Pharmaceuticals 3rd Generation EGFR Product Portfolios and Specifications
Table 85. Betta Pharmaceuticals 3rd Generation EGFR Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 86. Betta Pharmaceuticals Main Business
Table 87. Betta Pharmaceuticals Latest Developments
Table 88. Nanjing Sanhome Pharmaceutical Basic Information, 3rd Generation EGFR Manufacturing Base, Sales Area and Its Competitors
Table 89. Nanjing Sanhome Pharmaceutical 3rd Generation EGFR Product Portfolios and Specifications
Table 90. Nanjing Sanhome Pharmaceutical 3rd Generation EGFR Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 91. Nanjing Sanhome Pharmaceutical Main Business
Table 92. Nanjing Sanhome Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of 3rd Generation EGFR
Figure 2. 3rd Generation EGFR Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 3rd Generation EGFR Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global 3rd Generation EGFR Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. 3rd Generation EGFR Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Monoclonal Antibody Class
Figure 10. Product Picture of Small Molecule Tyrosine Kinase Inhibitors (TKIs)
Figure 11. Global 3rd Generation EGFR Sales Market Share by Type in 2022
Figure 12. Global 3rd Generation EGFR Revenue Market Share by Type (2018-2023)
Figure 13. 3rd Generation EGFR Consumed in Lung Cancer
Figure 14. Global 3rd Generation EGFR Market: Lung Cancer (2018-2023) & (K Pcs)
Figure 15. 3rd Generation EGFR Consumed in Liver Cancer
Figure 16. Global 3rd Generation EGFR Market: Liver Cancer (2018-2023) & (K Pcs)
Figure 17. 3rd Generation EGFR Consumed in Stomach Cancer
Figure 18. Global 3rd Generation EGFR Market: Stomach Cancer (2018-2023) & (K Pcs)
Figure 19. 3rd Generation EGFR Consumed in Other
Figure 20. Global 3rd Generation EGFR Market: Other (2018-2023) & (K Pcs)
Figure 21. Global 3rd Generation EGFR Sales Market Share by Application (2022)
Figure 22. Global 3rd Generation EGFR Revenue Market Share by Application in 2022
Figure 23. 3rd Generation EGFR Sales Market by Company in 2022 (K Pcs)
Figure 24. Global 3rd Generation EGFR Sales Market Share by Company in 2022
Figure 25. 3rd Generation EGFR Revenue Market by Company in 2022 ($ Million)
Figure 26. Global 3rd Generation EGFR Revenue Market Share by Company in 2022
Figure 27. Global 3rd Generation EGFR Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global 3rd Generation EGFR Revenue Market Share by Geographic Region in 2022
Figure 29. Americas 3rd Generation EGFR Sales 2018-2023 (K Pcs)
Figure 30. Americas 3rd Generation EGFR Revenue 2018-2023 ($ Millions)
Figure 31. APAC 3rd Generation EGFR Sales 2018-2023 (K Pcs)
Figure 32. APAC 3rd Generation EGFR Revenue 2018-2023 ($ Millions)
Figure 33. Europe 3rd Generation EGFR Sales 2018-2023 (K Pcs)
Figure 34. Europe 3rd Generation EGFR Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa 3rd Generation EGFR Sales 2018-2023 (K Pcs)
Figure 36. Middle East & Africa 3rd Generation EGFR Revenue 2018-2023 ($ Millions)
Figure 37. Americas 3rd Generation EGFR Sales Market Share by Country in 2022
Figure 38. Americas 3rd Generation EGFR Revenue Market Share by Country in 2022
Figure 39. Americas 3rd Generation EGFR Sales Market Share by Type (2018-2023)
Figure 40. Americas 3rd Generation EGFR Sales Market Share by Application (2018-2023)
Figure 41. United States 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC 3rd Generation EGFR Sales Market Share by Region in 2022
Figure 46. APAC 3rd Generation EGFR Revenue Market Share by Regions in 2022
Figure 47. APAC 3rd Generation EGFR Sales Market Share by Type (2018-2023)
Figure 48. APAC 3rd Generation EGFR Sales Market Share by Application (2018-2023)
Figure 49. China 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 53. India 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe 3rd Generation EGFR Sales Market Share by Country in 2022
Figure 57. Europe 3rd Generation EGFR Revenue Market Share by Country in 2022
Figure 58. Europe 3rd Generation EGFR Sales Market Share by Type (2018-2023)
Figure 59. Europe 3rd Generation EGFR Sales Market Share by Application (2018-2023)
Figure 60. Germany 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 61. France 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa 3rd Generation EGFR Sales Market Share by Country in 2022
Figure 66. Middle East & Africa 3rd Generation EGFR Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa 3rd Generation EGFR Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa 3rd Generation EGFR Sales Market Share by Application (2018-2023)
Figure 69. Egypt 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country 3rd Generation EGFR Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of 3rd Generation EGFR in 2022
Figure 75. Manufacturing Process Analysis of 3rd Generation EGFR
Figure 76. Industry Chain Structure of 3rd Generation EGFR
Figure 77. Channels of Distribution
Figure 78. Global 3rd Generation EGFR Sales Market Forecast by Region (2024-2029)
Figure 79. Global 3rd Generation EGFR Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global 3rd Generation EGFR Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global 3rd Generation EGFR Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global 3rd Generation EGFR Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global 3rd Generation EGFR Revenue Market Share Forecast by Application (2024-2029)